Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Pfizer Inc (NYSE:PFE)

34.26
Delayed Data
As of Sep 23
 +0.11 / +0.32%
Today’s Change
28.25
Today|||52-Week Range
37.39
+6.13%
Year-to-Date
Apple iPhone Calling Big Pharma: We Can Help You Develop Better Drugs
2:03pm / MotleyFool.com - Paid Partner Content
FDA AdCom Votes on Pfizer and Spectrum Drugs - What Next?
Sep 15 / Zacks.com - Paid Partner Content
The 5 Highest Dividend Payout Ratios on the Dow
Sep 23 / MotleyFool.com - Paid Partner Content
Aerie (AERI) Stock Up on Positive Phase III Data on Roclatan
Sep 15 / Zacks.com - Paid Partner Content
Dow 30 Stock Roundup: Microsoft Rewards Shareholders; GE Wins $1.9B Nuclear Power Con...
Sep 23 / Zacks.com - Paid Partner Content
Better Buy: Pfizer Inc. vs. AbbVie Inc.
Sep 15 / MotleyFool.com - Paid Partner Content
John Paulson Trims Synergy
Sep 23 / GuruFocus News - Paid Partner Content
Takeda earmarks $15bn for US pharma acquisitions
Sep 13 / FT.com - Paid Partner Content
Novartis (NVS) Zykadia Positive in Phase III ASCEND-4 Study
Sep 23 / Zacks.com - Paid Partner Content
3 Dividend Stocks to Buy in a Market Crash
Sep 13 / MotleyFool.com - Paid Partner Content
Will the Monsanto-Bayer Deal Go Through?
Sep 20 / GuruFocus News - Paid Partner Content
5 Biotech Stocks That Are Broker Favorites
Sep 13 / Zacks.com - Paid Partner Content
Sanofi Sues Merck Over Patent Infringement
Sep 20 / GuruFocus News - Paid Partner Content
Biotech Stocks Bounce Back in Monday Trading: 3 Picks
Sep 13 / Zacks.com - Paid Partner Content
Incoming GSK chief faces challenge to maintain momentum
Sep 20 / FT.com - Paid Partner Content
Why Pfizer's Stock Is a Big Gamble Right Now
Sep 13 / MotleyFool.com - Paid Partner Content
Big pharma targets drug-resistant superbugs
Sep 20 / FT.com - Paid Partner Content
Is Clovis Oncology Still a Strong Buy?
Sep 12 / MotleyFool.com - Paid Partner Content
Meet Big Pharma's new female CEO
Sep 20 / CNNMoney.com
2 Biotech Stocks that Turned $8,000 into over $250,000
Sep 12 / MotleyFool.com - Paid Partner Content
Pfizer (PFE) Breast Cancer Drug Ibrance Wins CHMP Backing
Sep 20 / Zacks.com - Paid Partner Content
Better Buy: Merck & Co., Inc. vs. Pfizer
Sep 12 / MotleyFool.com - Paid Partner Content
Stocks Trade Lower Monday With Global Central Bank Uncertainty
Sep 19 / GuruFocus News - Paid Partner Content
Gilead Sciencs, Inc. a Takeover Target? It's Not as Crazy As It Sounds
Sep 12 / MotleyFool.com - Paid Partner Content
Pfizer: Hospira Is Future; Xtandi Is Today's Meal
Sep 19 / GuruFocus News - Paid Partner Content
Two Things You Must Understand About Biotech Investing
Sep 11 / MotleyFool.com - Paid Partner Content
Is This New Market the Biggest Investment Idea of the Decade?
Sep 17 / MotleyFool.com - Paid Partner Content
CEO of Botox maker vows to limit price hikes
Sep 07 / CNNMoney.com
Forget Novavax, Buy These 4 Biotech Stocks Instead
Sep 16 / Zacks.com - Paid Partner Content
Apple and state aid: the end of the affair
Sep 02 / FT.com - Paid Partner Content
Pharma Stock Roundup: Acquisitions & Deals Pick Up Pace, Aerie Up on Positive Data
Sep 16 / Zacks.com - Paid Partner Content
Why the people of this Irish city love Apple
Sep 01 / CNNMoney.com
Merck/Pfizer Diabetes Drug Ertugliflozin Positive in Phase III
Sep 16 / Zacks.com - Paid Partner Content
Bristol-Myers Squibb misses mark with cancer drug
Aug 30 / FT.com - Paid Partner Content
FDA Panel Suggests Removing Warning from Pfizer's Chantix
Sep 15 / Zacks.com - Paid Partner Content
Mylan to launch cut-price generic version of EpiPen
Aug 29 / FT.com - Paid Partner Content